These results emphasize the potential of PKG to continuously and objectively measure bradykinesia, dyskinesia, tremor, sleep, and motor fluctuations (Griffiths et al., 2012; Odin et al., 2018). This evidence concerns the gene PRKG1 and drug-induced dyskinesia.